Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
US5389518A · kind A · utility
4Cited by
4References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 1994 |
| Grant date | Feb 14, 1995 |
| Priority date | — |
| Expiry date | Aug 1, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/825
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides monoclonal antibodies directed against specific domains of fibronectin and vitronectin. These monoclonals may be used in the production of the biomaterial and devices for use in in vitro cell culture. The present invention also provides an efficient method for extracting vitronectin from bovine serum or plasma using monoclonal antibodies and methods for analyzing biological samples for the presence of adhesive glycoproteins or fragments thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.